Hicham Majd’s Post

Next week, I’ll be moderating a panel on “Physical and Formulation Approaches for Brain Delivery” at Partnerships in Drug Delivery (PODD) 2025, taking place October 27–28 in Boston, MA. Our panel will feature leaders from Industry discussing the latest formulation and physical strategies to cross the blood–brain barrier (BBB) — a major frontier in developing effective brain-targeted therapeutics. Panelists: • Karla Sanchez, PhD. CNS Drug Delivery Lead, Cambridge Design Partnership • Mansuo Shannon, PhD. CSO, AskBio/Bayer • Peter Ahnblad, MD. Co-inventor, Co-Founder, HOGNE AB Together, we’ll explore emerging technologies, translational challenges, and collaborative approaches that are redefining what’s possible in #DrugDelivery and #Neuroscience. Looking forward to connecting with colleagues, innovators, and thought leaders driving the next generation of brain delivery solutions in Boston! #PODD2025 #BBB #FormulationScience #PharmaInnovation #DrugDevelopment #BrainDelivery Karla E. Sanchez, Peter Ahnblad and Mansuo L Shannon,